Igor Age Kos

606 total citations
28 papers, 280 citations indexed

About

Igor Age Kos is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Igor Age Kos has authored 28 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 8 papers in Immunology and 7 papers in Oncology. Recurrent topics in Igor Age Kos's work include Lymphoma Diagnosis and Treatment (8 papers), Biosimilars and Bioanalytical Methods (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Igor Age Kos is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Biosimilars and Bioanalytical Methods (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Igor Age Kos collaborates with scholars based in Germany, Brazil and Croatia. Igor Age Kos's co-authors include Valderílio Feijó Azevedo, Geraldo da Rocha Castelar Pinheiro, Eduardo dos Santos Paiva, Ana Beatriz Vargas‐Santos, Ν. Moussiopoulos, Lorenz Thurner, Moritz Bewarder, Zvjezdana Bencetić Klaić, Dominic Kaddu‐Mulindwa and Branko Grisogono and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Igor Age Kos

23 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor Age Kos Germany 8 87 49 47 45 38 28 280
Mohammad Ilyas United States 11 56 0.6× 49 1.0× 91 1.9× 34 0.8× 46 1.2× 30 417
Xiaoting Shen China 15 41 0.5× 41 0.8× 123 2.6× 12 0.3× 12 0.3× 39 637
António Castro Henriques Portugal 13 57 0.7× 31 0.6× 19 0.4× 10 0.2× 39 1.0× 40 578
Le‐Feng Chen China 12 14 0.2× 53 1.1× 81 1.7× 13 0.3× 49 1.3× 25 397
Alessandra Beltrame Brazil 7 163 1.9× 12 0.2× 41 0.9× 24 0.5× 3 0.1× 13 362
Ahmed Khalil Egypt 11 19 0.2× 41 0.8× 54 1.1× 10 0.2× 10 0.3× 60 399
Zheng Wei China 7 32 0.4× 5 0.1× 49 1.0× 8 0.2× 74 1.9× 11 291
Abdoulaye Pouye Senegal 9 40 0.5× 15 0.3× 19 0.4× 24 0.5× 17 0.4× 67 240
Meena Rafiq United Kingdom 9 82 0.9× 5 0.1× 54 1.1× 41 0.9× 83 2.2× 31 495
Axelle Dupont France 10 14 0.2× 22 0.4× 11 0.2× 42 0.9× 76 2.0× 25 283

Countries citing papers authored by Igor Age Kos

Since Specialization
Citations

This map shows the geographic impact of Igor Age Kos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Age Kos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Age Kos more than expected).

Fields of papers citing papers by Igor Age Kos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Age Kos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Age Kos. The network helps show where Igor Age Kos may publish in the future.

Co-authorship network of co-authors of Igor Age Kos

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Age Kos. A scholar is included among the top collaborators of Igor Age Kos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Age Kos. Igor Age Kos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brünner, Franziska, Mathias Haenel, Igor Age Kos, et al.. (2025). Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden. Blood Advances. 10(7). 2186–2189.
2.
Neumann, Frank, Konstantinos Christofyllakis, Igor Age Kos, et al.. (2024). Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas. Scientific Reports. 14(1). 9571–9571. 1 indexed citations
3.
Fadle, Natalie, Evi Regitz, Igor Age Kos, et al.. (2024). Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis. Immunology Letters. 270. 106926–106926. 2 indexed citations
4.
5.
Bewarder, Moritz, Konstantinos Christofyllakis, Gerhard Held, et al.. (2024). Cytomegalovirus-Specific T-Cell-Receptor-like Antibodies Target In Vivo-Infected Human Leukocytes Inducing Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity. International Journal of Molecular Sciences. 25(23). 12908–12908.
6.
Christofyllakis, Konstantinos, Dominic Kaddu‐Mulindwa, Igor Age Kos, et al.. (2024). An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma. Annals of Hematology. 103(11). 4599–4606. 2 indexed citations
7.
Bewarder, Moritz, Dominic Kaddu‐Mulindwa, Igor Age Kos, et al.. (2023). Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP. Haematologica. 108(10). 2844–2849. 2 indexed citations
8.
Christofyllakis, Konstantinos, Frank Neumann, Moritz Bewarder, et al.. (2023). Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies. Nutrients. 15(16). 3498–3498. 5 indexed citations
9.
Kos, Igor Age, Joerg Thomas Bittenbring, Manfred Ahlgrimm, et al.. (2022). Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2. Expert Review of Vaccines. 21(11). 1683–1689. 1 indexed citations
10.
Kaddu‐Mulindwa, Dominic, Lorenz Thurner, Konstantinos Christofyllakis, Moritz Bewarder, & Igor Age Kos. (2022). Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives. Cancers. 14(12). 3019–3019. 7 indexed citations
11.
Christofyllakis, Konstantinos, et al.. (2022). Biomarker guided treatment in oncogene-driven advanced non-small cell lung cancer in older adults: A Young International Society of Geriatric Oncology report. Journal of Geriatric Oncology. 13(8). 1071–1083. 2 indexed citations
12.
Kos, Igor Age, Lorenz Thurner, Joerg Thomas Bittenbring, Konstantinos Christofyllakis, & Dominic Kaddu‐Mulindwa. (2021). Advances in Lymphoma Molecular Diagnostics. Diagnostics. 11(12). 2174–2174. 4 indexed citations
13.
Bewarder, Moritz, Carlos Metz, André Becker, et al.. (2021). Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019. Intensive Care Medicine Experimental. 9(1). 45–45. 4 indexed citations
14.
Kos, Igor Age, Sophie Roth, Manfred Ahlgrimm, et al.. (2020). Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab. Frontiers in Oncology. 10. 1578–1578. 44 indexed citations
15.
Kos, Igor Age, Stephan Stilgenbauer, & Moritz Bewarder. (2020). Renal AA amyloidosis leading to early diagnosis and treatment of takayasu arteritis: a case report and review of the literature. Clinical Research in Cardiology. 109(11). 1438–1441. 3 indexed citations
16.
Azevedo, Valderílio Feijó, Igor Age Kos, Ana Beatriz Vargas‐Santos, Geraldo da Rocha Castelar Pinheiro, & Eduardo dos Santos Paiva. (2019). Benzbromarone in the treatment of gout. Advances in Rheumatology. 59(1). 37–37. 110 indexed citations
17.
Scheinberg, Morton, et al.. (2018). Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market. Einstein (São Paulo). 16(3). eRW4175–eRW4175. 8 indexed citations
18.
Kos, Igor Age, et al.. (2018). The biosimilars journey: current status and ongoing challenges. Drugs in Context. 7. 1–13. 12 indexed citations
19.
Kos, Igor Age, et al.. (2005). An Improved Ekman Layer Approximation for Smooth Eddy Diffusivity Profiles. Boundary-Layer Meteorology. 115(3). 399–407. 20 indexed citations
20.
Kos, Igor Age, et al.. (2004). Education and research: Initial development of the Atmospheric Lagrangian Particle Stochastic (ALPS) Dispersion Model. Geofizika. 21(1). 37–52. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad Ilyas Breakdown of academic impact, for papers by Xiaoting Shen Breakdown of academic impact, for papers by António Castro Henriques Breakdown of academic impact, for papers by Le‐Feng Chen Breakdown of academic impact, for papers by Alessandra Beltrame Breakdown of academic impact, for papers by Ahmed Khalil Breakdown of academic impact, for papers by Zheng Wei Breakdown of academic impact, for papers by Abdoulaye Pouye Breakdown of academic impact, for papers by Meena Rafiq Breakdown of academic impact, for papers by Axelle Dupont
Rankless by CCL
2026